
Master Class Overview
Since we will be in our nation’s capital this April, OIS is teaming up with the CDRH to create a unique Master Class focusing on Pathways for Expediting Ophthalmic Device Innovation.
The OIS@ASCRS Master Class, will feature CDRH staff members discussing novel mechanisms and pathways aimed at facilitating innovation. Some of these pathways include Digital Health Functionality Initiatives to foster innovation in ophthalmic devices, a decrease in total time to decision for 510(k) submissions, and providing early evaluation of small human clinical studies to help improve development strategies for expedited accessibility of certain products intended for unmet public health needs. Additionally, we incorporate patients’ perspectives into device development and evaluation process through improved use of patient reported outcomes (PROs) and patient preference information (PPI).
The discussion will enable attendees to have suitable resources to address scientific and regulatory challenges raised by innovative devices. CDRH is committed to have a product's timely progress to market without compromising safety or effectiveness with patients as the ultimate beneficiaries.
Speakers

Agenda
Friday, April 13, 2018
8:00 - 8:30 AM
Check-in & Networking Breakfast
8:30 - 8:35 AM
Welcome Remarks
8:35 - 9:05 AM
Mechanisms to Decrease Total Time to Decision (TTD) for Ophthalmic 510(k) Submissions
Presented By:
Denise Hampton, PhD, Associate Director - DOED/CDRH/FDA
9:05 - 9:35 AM
Digital Health Functionality Initiatives to Foster Innovation in Ophthalmic Devices
Presented By:
Ron Schuchard, PhD, Medical Physicist - DSDB/DOED/CDRH/FDA
9:35 - 10:05 AM
Patient Reported Outcomes (PROs) and Patient Preference Information (PPI)
Presented By:
Michelle Tarver, MD, PhD, Medical Officer - DOED/CDRH/FDA
10:05 - 10:35 AM
Networking & Refreshment Break
10:35 - 11:05 AM
FDA’s Early Feasibility Study (EFS) Program
Presented By:
Angelo Green, PhD, Acting Branch Chief - CLRD/DOED/CRDH/FDA
11:05 - 11:35 AM
Overview of Humanitarian Device Exemption (HDE) and Breakthrough Devices Program
Presented By:
Tieuvi Nguyen, PhD, Chief - ICIB/DOED/CDRH/FDA
11:35 - 12:05 PM
Open Q&A
Participants:
Malvina Eydelman, MD, Director - DOED/CDRH/FDA
Angelo Green, PhD, Acting Branch Chief - CLRD/DOED/CRDH/FDA
Denise Hampton, PhD, Associate Director - DOED/CDRH/FDA
Tieuvi Nguyen, PhD, Chief - ICIB/DOED/CDRH/FDA
Ron Schuchard, PhD, Medical Physicist - DSDB/DOED/CDRH/FDA
Michelle Tarver, MD, PhD, Medical Officer - DOED/CDRH/FDA
*
- Division of Ophthalmic and Ear, Nose and Throat Devices (DOED)
- Center for Devices and Radiological Health (CDRH)
- Diagnostic and Surgical Devices Branch (DSDB)
- Contact Lens and Retinal Devices Branch (CLRD)
- Intraocular and Corneal Implants Branch (ICIB)
DOWNLOAD THE FDA REFERENCE LIST
Venue
Renaissance Washington, DC Downtown Hotel
999 Ninth Street NW Washington
District of Columbia 20001
(202) 898-9000
